Evidence map›Paper›PMID 39007142›Full record

ArticleFrontiers in immunology2024

Dynamic establishment and maintenance of the human intestinal B cell population and repertoire following transplantation in a pediatric-dominated cohort.

Jianing Fu, Thomas Hsiao, Elizabeth Waffarn, Wenzhao Meng, Katherine D Long, Kristjana Frangaj, Rebecca Jones, Alaka Gorur, Areen Shtewe, Muyang Li and 19 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Chimerism-Mediated Tolerance in Intestinal Transplantation.Gastroenterology clinics of North America · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Jianing Fu *Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Thomas Hsiao *Department of Human Biology, University of Haifa, Haifa, Israel.
Elizabeth Waffarn *Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Wenzhao MengDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Katherine D LongColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Kristjana FrangajColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Rebecca JonesColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Alaka GorurColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Areen ShteweDepartment of Human Biology, University of Haifa, Haifa, Israel.
Muyang LiDepartment of Pathology, Columbia University, New York, NY, United States.
Constanza Bay MuntnichColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Kortney RogersColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Wenyu JiaoColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Monica VelascoDepartment of Pediatrics, Columbia University, New York, NY, United States.
Rei MatsumotoDepartment of Microbiology and Immunology, Columbia University, New York, NY, United States.
Masaru KubotaDepartment of Microbiology and Immunology, Columbia University, New York, NY, United States.
Steven WellsDepartment of Microbiology and Immunology, Columbia University, New York, NY, United States.
Nichole DanzlColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Shilpa RavellaDivision of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, United States.
Alina IugaDepartment of Pathology, Columbia University, New York, NY, United States.
Elena-Rodica VasilescuDepartment of Pathology, Columbia University, New York, NY, United States.
Adam GriesemerColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Joshua WeinerColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Donna L FarberDepartment of Microbiology and Immunology, Columbia University, New York, NY, United States.
Eline T Luning PrakDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Mercedes MartinezDepartment of Pediatrics, Columbia University, New York, NY, United States.
Tomoaki KatoDepartment of Surgery, Columbia University, New York, NY, United States.
Uri HershbergDepartment of Human Biology, University of Haifa, Haifa, Israel.
Megan SykesColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ronald G Collman · 1999 to 2026
$78.6M
Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber · 2013 to 2026
$31.3M
Training in Translational Immunology ResearchT32AI148099 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SYKES, MEGAN · 2020 to 2024
$1.4M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCI NIH HHS P30 CA016520NCRR NIH HHS S10 RR027050NIAID NIH HHS P01 AI106697NIAID NIH HHS P30 AI045008NIAID NIH HHS T32 AI148099NIH HHS S10 OD020056
6 · The paper itself

Abstract

Introduction: It is unknown how intestinal B cell populations and B cell receptor (BCR) repertoires are established and maintained over time in humans. Following intestinal transplantation (ITx), surveillance ileal mucosal biopsies provide a unique opportunity to map the dynamic establishment of recipient gut lymphocyte populations in immunosuppressed conditions. Methods: Using polychromatic flow cytometry that includes HLA allele group-specific antibodies distinguishing donor from recipient cells along with high throughput BCR sequencing, we tracked the establishment of recipient B cell populations and BCR repertoire in the allograft mucosa of ITx recipients. Results: We confirm the early presence of naïve donor B cells in the circulation (donor age range: 1-14 years, median: 3 years) and, for the first time, document the establishment of recipient B cell populations, including B resident memory cells, in the intestinal allograft mucosa (recipient age range at the time of transplant: 1-44 years, median: 3 years). Recipient B cell repopulation of the allograft was most rapid in infant (<1 year old)-derived allografts and, unlike T cell repopulation, did not correlate with rejection rates. While recipient memory B cell populations were increased in graft mucosa compared to circulation, naïve recipient B cells remained detectable in the graft mucosa for years. Comparisons of peripheral and intra-mucosal B cell repertoires in the absence of rejection (recipient age range at the time of transplant: 1-9 years, median: 2 years) revealed increased BCR mutation rates and clonal expansion in graft mucosa compared to circulating B cells, but these parameters did not increase markedly after the first year post-transplant. Furthermore, clonal mixing between the allograft mucosa and the circulation was significantly greater in ITx recipients, even years after transplantation, than in deceased adult donors. In available pan-scope biopsies from pediatric recipients, we observed higher percentages of naïve recipient B cells in colon allograft compared to small bowel allograft and increased BCR overlap between native colon vs colon allograft compared to that between native colon vs ileum allograft in most cases, suggesting differential clonal distribution in large intestine vs small intestine. Discussion: Collectively, our data demonstrate intestinal mucosal B cell repertoire establishment from a circulating pool, a process that continues for years without evidence of stabilization of the mucosal B cell repertoire in pediatric ITx patients.

Indexed as

Intestinal MucosaReceptors, Antigen, B-CellAdolescentAdultB-LymphocytesChildChild, PreschoolFemaleGraft RejectionHumansInfantIntestinesMaleOrgan TransplantationYoung AdultReceptors, Antigen, B-CellB cell repertoire sequencingB cell subpopulationshuman longitudinal studiesintestinal transplantationresident memory B cells

Identifiers

PMID39007142
PMCPMC11239347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.